OWP
GHDX

Obermeyer Wealth Partners’s Genomic Health, Inc. GHDX Stock Holding History

Obermeyer Wealth Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-130
Closed -$4K – 320
2013
Q2 		$4K Buy
+130
New +$4.27K ﹤0.01% 320

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Obermeyer Wealth Partners's GHDX Position: Q3 2013 in Review

Obermeyer Wealth Partners sold out of Genomic Health, Inc. (GHDX) in Q3 2013, closing a stake of 130 shares — an estimated $4K sold.

Obermeyer Wealth Partners first reported a position in GHDX in Q2 2013 and held it in 1 quarter. The position peaked at $4K in Q2 2013. 111 funds tracked by Wall St. Rank hold GHDX as of Q3 2013.

  • Obermeyer Wealth Partners reported no remaining Genomic Health, Inc. position as of Q3 2013 after selling out during the quarter.
  • Obermeyer Wealth Partners sold 130 Genomic Health, Inc. shares in Q3 2013, an estimated $4K.
  • Obermeyer Wealth Partners first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 1 quarter.
  • Obermeyer Wealth Partners's Genomic Health, Inc. position peaked at $4K in Q2 2013.
  • 111 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2013.

Based on Obermeyer Wealth Partners's 13F filing for Q3 2013, filed 18 Oct 2013.